EVAX · Evaxion A/S · Documents
Market Cap
$33.47M
Shares
9.02M
Volume · Oct 21
326.11K
Avg daily vol (3M)
221.76K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | Evaxion A/S announced that all patients in the EVX-01 phase 2 trial in advanced melanoma maintained clinical responses at three-year follow-up with no tumor progression, supplementing prior 75% Objective Response Rate data with 25% complete responses. | 2026-10-19 | — | |
| 6-K | — | 2026-10-02 | — | |
| 6-K | — | 2026-09-14 | — | |
| 6-K | — | 2026-09-04 | — | |
| 6-K | — | 2026-08-20 | 2026-06-30 | |
| 6-K | — | 2026-08-20 | — | |
| 6-K | — | 2026-08-17 | — | |
| 6-K | — | 2026-08-14 | — | |
| 6-K | — | 2026-07-17 | — | |
| 6-K | — | 2026-07-13 | 2026-07-12 | |
| 6-K | — | 2026-07-01 | — | |
| 6-K | — | 2026-06-12 | — | |
| 6-K | — | 2026-06-11 | — | |
| 6-K | — | 2026-05-12 | — | |
| 6-K | — | 2026-05-07 | — | |
| 6-K | — | 2026-05-04 | — | |
| 6-K | — | 2026-04-27 | — | |
| 6-K | — | 2026-04-22 | 2026-04-21 | |
| 6-K | — | 2026-04-17 | — | |
| 6-K | — | 2026-04-17 | — | |
| 6-K | — | 2026-04-16 | — | |
| 6-K | — | 2026-04-07 | — | |
| 6-K | — | 2026-03-30 | — | |
| 6-K | — | 2026-03-19 | — | |
| 6-K | — | 2026-03-19 | — | |
| 6-K | — | 2026-03-17 | — | |
| 6-K | — | 2026-03-05 | — | |
| 20-F | — | 2026-03-05 | 2025-12-31 | |
| 6-K | — | 2026-03-05 | — | |
| 6-K | — | 2026-03-02 | — | |
| 6-K | — | 2026-02-27 | — | |
| 6-K | — | 2026-01-13 | — | |
| 6-K | — | 2026-01-07 | — | |
| 6-K | — | 2025-12-19 | — | |
| 6-K | — | 2025-12-10 | — | |
| 6-K | — | 2025-12-08 | 2025-12-06 | |
| F-1 | — | 2025-11-21 | — | |
| 6-K | — | 2025-11-20 | — | |
| 6-K | — | 2025-11-18 | — | |
| 6-K | — | 2025-11-12 | — | |
| 6-K | — | 2025-11-07 | — | |
| 6-K | — | 2025-11-06 | — | |
| 6-K | — | 2025-11-03 | — | |
| 6-K | — | 2025-10-31 | — | |
| 6-K/A | — | 2025-10-31 | — | |
| 6-K | — | 2025-10-30 | — | |
| 6-K | — | 2025-10-30 | — | |
| 6-K | — | 2025-10-27 | — | |
| 6-K | — | 2025-10-17 | — | |
| 6-K | — | 2025-10-17 | — |
Showing 1–50 of 275 filings